Literature DB >> 28405017

Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Katarzyna Kasperkiewicz1, Łukasz Eppa2, Anna S Świerzko2, Marcin A Bartłomiejczyk2, Zbigniew M Żuber3, Katarzyna Siniewicz-Luzeńczyk4, Elżbieta Mężyk3, Misao Matsushita5, Leokadia Bąk-Romaniszyn6, Krzysztof Zeman4, Mikael Skurnik7,8, Maciej Cedzyński2.   

Abstract

Both complement activation and certain infections (including those with Yersinia sp.) may contribute to the pathogenesis of juvenile idiopathic arthritis (JIA). We investigated factors specific for the lectin pathway of complement: mannose-binding lectin (MBL), ficolins and MBL-associated serine protease-2 (MASP-2), in 144 patients and 98 controls. One hundred and six patients had oligoarticular disease and 38 had polyarticular disease. In 51 patients (out of 133 tested), Yersinia-reactive antibodies were found (JIA Ye+ group). MBL deficiency was significantly more frequent in the JIA Ye+ group than in patients without Yersinia-reactive antibodies or in controls. Median serum ficolin-2 level was significantly lower (and proportion of values deemed ficolin-2 insufficient greater) in JIA patients irrespective of their Yersinia antibody status. The minority (C) allele at -64 of the FCN2 gene was less frequent among JIA patients than among control subjects. No differences were found in the frequency of FCN3 gene +1637delC or MASP2 +359 A>G mutations nor for median values of serum ficolin-1, ficolin-3 or MASP-2. However, high levels of serum ficolin-3 were under-represented in patients, in contrast to MBL. MBL, ficolin-1, ficolin-2, ficolin-3 and MASP-2 were also readily detectable in synovial fluid samples but at a considerably lower level than in serum. Our findings suggest a possible role for the lectin pathway in the pathogenesis of JIA, perhaps secondary to a role in host defence, and indicate that investigations on the specificity of lectin pathway recognition molecules towards specific infectious agents in JIA might be fruitful.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28405017     DOI: 10.1038/icb.2017.31

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  49 in total

Review 1.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

2.  Blood collection tubes influence serum ficolin-1 and ficolin-2 levels.

Authors:  Allison M Brady; Brady L Spencer; Ann R Falsey; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease.

Authors:  Leokadia Bak-Romaniszyn; Agnieszka Szala; Anna Sokolowska; Grazyna Mierzwa; Mieczyslawa Czerwionka-Szaflarska; Anna St Swierzko; Krzysztof Zeman; Maciej Cedzynski
Journal:  Scand J Gastroenterol       Date:  2011-06-27       Impact factor: 2.423

Review 4.  Juvenile idiopathic arthritis.

Authors:  Berent Prakken; Salvatore Albani; Alberto Martini
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

5.  Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.

Authors:  Brooke E Gilliam; Melinda R Reed; Anil K Chauhan; Amanda B Dehlendorf; Terry L Moore
Journal:  Clin Exp Rheumatol       Date:  2011-12-22       Impact factor: 4.473

6.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Lipopolysaccharide accelerates collagen-induced arthritis in association with rapid and continuous production of inflammatory mediators and anti-type II collagen antibody.

Authors:  Shinji Tanaka; Tadashi Toki; Toshihiko Akimoto; Kaoru Morishita
Journal:  Microbiol Immunol       Date:  2013-06       Impact factor: 1.955

8.  Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures.

Authors:  Estrid Hein; Jakob T Bay; Lea Munthe-Fog; Peter Garred
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

9.  Cost-effective procedures for genotyping of human FCN2 gene single nucleotide polymorphisms.

Authors:  Agnieszka Szala; Anna St Swierzko; Maciej Cedzynski
Journal:  Immunogenetics       Date:  2013-03-23       Impact factor: 2.846

10.  Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours.

Authors:  Anna St Swierzko; Agnieszka Szala; Sambor Sawicki; Janusz Szemraj; Marcin Sniadecki; Anna Sokolowska; Andrzej Kaluzynski; Dariusz Wydra; Maciej Cedzynski
Journal:  Cancer Immunol Immunother       Date:  2014-07-20       Impact factor: 6.968

View more
  7 in total

1.  Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever.

Authors:  Sandra Jeremias Catarino; Fabiana Antunes Andrade; Angelica Beate Winter Boldt; Luiza Guilherme; Iara Jose Messias-Reason
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

2.  The Role of Yersinia enterocolitica O:3 Lipopolysaccharide in Collagen-Induced Arthritis.

Authors:  Katarzyna Kasperkiewicz; Anna S Świerzko; Marta Przybyła; Janusz Szemraj; Jarosław Barski; Mikael Skurnik; Andrzej Kałużyński; Maciej Cedzyński
Journal:  J Immunol Res       Date:  2020-11-12       Impact factor: 4.818

3.  The clinical value of ficolin-3 gene polymorphism in rheumatic heart disease. An Egyptian adolescents study.

Authors:  Maher H Gomaa; Emad Gamil Khidr; Ahmed Elshafei; Hala S Hamza; Aya M Fattouh; Ahmed A El-Husseiny; Ahmed Aglan; Mahmoud Gomaa Eldeib
Journal:  BMC Res Notes       Date:  2021-01-26

4.  Polymorphisms of the FCN2 Gene 3'UTR Region and Their Clinical Associations in Preterm Newborns.

Authors:  Anna S Świerzko; Dariusz Jarych; Gabriela Gajek; Karolina Chojnacka; Paulina Kobiela; Maja Kufelnicka-Babout; Mateusz Michalski; Katarzyna Sobczuk; Agnieszka Szala-Poździej; Misao Matsushita; Jan Mazela; Iwona Domżalska-Popadiuk; David C Kilpatrick; Jarosław Kalinka; Hideharu Sekine; Maciej Cedzyński
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

5.  M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis.

Authors:  Ninna Brix; Mia Glerup; Steffen Thiel; Clara Elbæk Mistegaard; Regitze Gyldenholm Skals; Lillemor Berntson; Anders Fasth; Susan Mary Nielsen; Ellen Nordal; Marite Rygg; Henrik Hasle; Birgitte Klug Albertsen; Troels Herlin
Journal:  Arch Dis Child       Date:  2021-10-22       Impact factor: 3.791

6.  Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.

Authors:  Mia Glerup; Steffen Thiel; Veronika Rypdal; Ellen Dalen Arnstad; Maria Ekelund; Suvi Peltoniemi; Kristiina Aalto; Marite Rygg; Susan Nielsen; Anders Fasth; Lillemor Berntson; Ellen Nordal; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2019-09-09       Impact factor: 3.054

7.  European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.

Authors:  Nicholas Brodszki; Ashley Frazer-Abel; Anete S Grumach; Michael Kirschfink; Jiri Litzman; Elena Perez; Mikko R J Seppänen; Kathleen E Sullivan; Stephen Jolles
Journal:  J Clin Immunol       Date:  2020-02-17       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.